In recognition of his pioneering work on the interplay between ER and HER2 signaling, Dr. Osborne will be the special guest at this symposium bearing his name. Speakers will explore what is known about the crosstalk between these signaling pathways, how it takes place, and the latest evidence on the most effective therapies for patients…

In the first of two new ‘Controversies’ sessions at SABCS 2022, Lisa Carey, MD, ScM, FASCO, will lead discussions by experts on three important topics in breast cancer clinical care.

Aditya Bardia, MD, MPH, will moderate this year’s Clinical Research Workshop. Among the presentations, Dawn L. Hershman, MD, MS, will discuss drug adherence in clinical trials.